Substance
ELOTUZUMAB
Global reference: every product and company linked to this substance.
- cas: 915296-00-3
- ncit: C66982
- rxnorm: 1726104
- unii: 1351PE5UGS
BMS-901608 · elotuzumab [INN] · ELOTUZUMAB [JAN] · ELOTUZUMAB [USAN] · Elotuzumab [WHO-DD] · EMPLICITI · HULUC63 · PDL-063 · PDL063
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK | EMPLICITI | Q4 2022 | $71.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- EMPLICITI · BRISTOL-MYERS SQUIBB COMPANY COMMON STOCK